James Henderson Joins SG Blocks as Director of Medical Business Development

Brings more than 10 years’ experience in the medical sales field, and will lead the Company’s medical vertical as demand within the sector grows

SG Blocks, Inc. (NASDAQ: SGBX) (“SG Blocks” or the “Company”), a leading designer, innovator and fabricator of modular structures, announced today that medical sales industry veteran James Henderson will join the team as Director of Medical Business Development.

“We’re excited to welcome James to the team. We crafted this role specifically for him, aligning directly with his expertise, background and experience,” Paul Galvin, Chairman & CEO explained. “He’s a great fit for our overarching sales & business development team, and we think he will do a fantastic job at leading our expanding medical sector. As our business grows, we continue to look to industry specialists within each of our verticals to drive revenue and bottom line. Our ability to expand in this way is a testament to what we have built, and the opportunity we have in front of us.”

In the newly created role, Mr. Henderson will lead sales and business development for the Company’s medical vertical, which has seen tremendous growth during the past year. His role will include, but is not limited to, managing business development initiatives, supply chain logistics and day to day operations as it relates to the Company’s medical subdivision. He brings with him an expansive list of contacts and relationships within the medical industry, having spent over 10 years managing field sales, increasing product sales, and managing direct and indirect reports from multiple divisions to attain growth targets and customer satisfaction.

Mr. Henderson’s most recent role was with Owens & Minor Inc., a Fortune 500 global healthcare logistics company, in which Mr. Henderson served as a Client Executive, managing a sales territory that generated millions in revenue and was a top performing director.

“It’s a great feeling to be stacking our team with some of the best and brightest in their respective fields,” continued Mr. Galvin. “Our business is so nimble and can do so many things, it truly brings together an impressive group of people.”

About SG Blocks, Inc.

SG Blocks, Inc. is a premier innovator in advancing and promoting the use of code-engineered cargo shipping containers for safe and sustainable construction. The firm offers a product that exceeds many standard building code requirements, and also supports developers, architects, builders and owners in achieving greener construction, faster execution, and stronger buildings of higher value. Each project starts with GreenSteel™, the structural core and shell of an SG Blocks building, and then customized to client specifications. For more information, visit www.sgblocks.com.

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements regarding the expected contribution of Mr. Henderson. While SG Blocks believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, Mr. Henderson’s ability to expand sales and business development for the Company’s medical vertical, the Company’s ability to expand within various verticals as planned, the Company’s ability to position itself for future profitability, the Company’s ability to maintain compliance with the NASDAQ listing requirements, and the other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211105005257/en/